Trial reportBMC anesthesiology2025
Effects of sufentanil combined with remifentanil on hemodynamics during induction and postoperative recovery quality in preschool children undergoing tonsillectomy and adenoidectomy.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis study was designed to assess the effects of sufentanil combined with remifentanil on hemodynamics during induction and postoperative recovery quality in preschool children undergoing tonsillectomy and adenoidectomy.
methodsA total of 90 pediatric patients undergoing tonsillectomy and adenoidectomy under general anesthesia from October 2024 to March 2025 were included and randomly stratified to receive either Group R or Group S with equal probability. In Group R, anesthesia induction used sufentanil (0.2 µg/kg) combined with remifentanil (2 µg/kg), while only sufentanil (0.4 µg/kg) was used for anesthesia induction in Group S. The rest of the induction drugs were the same in both groups. After drug administration, patient vital signs, such as heart rate (HR) and mean arterial pressure (MAP), were monitored and recorded before induction (T0), immediately before tracheal intubation (T1), 1 min after tracheal intubation (T2), immediately after mouth gag placement (T3), immediately after extubation (T4), and 5 min post-extubation (T5), respectively. Additional outcomes of interest included anesthesia recovery time, an intubation condition score (Copenhagen Consensus Scale), emergence agitation (Pediatric Anesthesia Emergence Delirium [PAED] score), a postoperative pain assessment score (Face, Legs, Activity, Cry, and Consolability [FLACC] score), and adverse events.
resultsThe primary outcome is postoperative awakening time (the time from the end of surgery to tracheal tube removal), which was shorter in Group R than in Group S, but this difference was not statistically significant (P > 0.05). The secondary outcomes include intraoperative hemodynamic parameters, intubation condition score (Copenhagen Consensus Scale), emergence agitation (Pediatric Anesthesia Emergence Delirium [PAED] score), a postoperative pain assessment score (Face, Legs, Activity, Cry, and Consolability [FLACC] score), and adverse events containing agitation during the awakening period, respiratory obstruction, nausea and vomiting, hypoxemia, and bradycardia. MAP was lower in Group R than in Group S at all time points, and was significantly lower at T3 (P < 0.05). HR was lower in Group R than in Group S at most time points, including being significantly lower at T2 (P < 0.05). No statistically significant differences were found between the two groups among the aforementioned secondary outcomes.
conclusionsAmong preschool children undergoing tonsillectomy and adenoidectomy, the combination of sufentanil and remifentanil in general anesthesia ensured stable hemodynamics during induction and surgery, reduced the total dose of opioid anesthetics, shortened recovery time without compromising quality, and led to no significant adverse reactions.
trial registrationChina Clinical Trial Center with registration number: ChiCTR2400090213,09/26/2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.